Contact Us
Search for:
About Nanoform
About Nanoform
Vision, mission and values
Organization
Board of Directors
CEO and Management Team
Success stories
Corporate Responsibility
Technology
Technology
CESS
®
STARMAP
®
Biologics
Formulations
Case studies
Services
Services
GMP Manufacturing
Corporate Governance
Corporate Governance
Corporate Governance Statements
General meeting
Annual General Meeting 2022
General meetings
The Board of Directors
Board of Directors
Duties of the Board of Directors
Authorisations
Board committees
Remuneration of the Board
CEO and Management Team
Remuneration
Audit
Internal Control and Risk Management
Code of conduct
Articles of Association
Insider administration
Disclosure policy
Transcations of managers
Investors
Investors
Investerare
Sijoittajat
Financial Reports and Presentations
Press releases
Subscribe
Share and shareholders
Share information
Share capital development
Certified Adviser
Analyst Coverage
Ownership structure
Notifications of major shareholdings
Manager Transactions
IPO 2020
Investor calendar
Contact
Finansiella rapporter och presentationer
Pressmeddelanden
Prenumerera
Aktien och aktieägare
Aktieinformation
Aktiekapitalets utveckling
Certified Adviser
Analytiker
Ägarstruktur
Anmälan om betydande aktieägare
Transaktioner utförda av personer i ledande ställning
Börsnotering
Investerarkalender
Kontakt
Taloudelliset raportit ja esitykset
Tiedotteet
Tilaaminen
Osake ja osakkeeomistajat
Tiedot osakkeesta
Osakepääoman kehitys
Hyväksytty neuvonantaja
Analyytikot
Omistusrakenne
Ilmoitukset merkittävistä osakkeenomistajista
Johtohenkilöiden liiketoimet
Listautuminen
Sijoittajakalenteri
Yhteystiedot
Media
Media
Press releases
News
Pharmaceutical events
Articles & videos
Subscribe
Brochure
Contact
Careers
Contact
Search for:
Success stories
July 14, 2022
Nanoform and Pharmanovia to breathe new life into iconic medicines
May 6, 2022
Nanoform’s collaboration with TargTex
May 4, 2022
Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers
March 22, 2022
Nanoform successfully completes new share issue raising EUR 25 million to prepare for GMP manufacturing in the USA
March 11, 2022
Nanoform triples its GMP capacity and adds high potent handling (OEL <30 ng/m3) capabilities to its Helsinki facility to meet increasing demand.
November 17, 2021
Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021
September 29, 2021
Nanoform receives funding to solve challenges for global health
September 9, 2021
Nanoform technology delivers successful results for Herantis CDNF drug candidate
August 3, 2021
Nanoform and Boehringer Ingelheim execute master services agreement
May 18, 2021
Nanoform’s final clinical results confirm value proposition to the pharma industry
May 4, 2020
Nanoform awarded GMP certification
November 6, 2019
Nanoform wins the CPhI Excellence in Pharma Award for Formulation
